%0 Journal Article
%T Juvenile Systemic Sclerosis: About 9 Cases
%A Kaoutar Danaoui
%A Houda Nassih
%A Khadija Oujennane
%A Rabiy El Qadiry
%A Aicha Bourrahouat
%A Said Amal
%A Imane Ait Sab
%J Open Journal of Pediatrics
%P 320-326
%@ 2160-8776
%D 2024
%I Scientific Research Publishing
%R 10.4236/ojped.2024.142031
%X Scleroderma is a rare disease with two primary
forms: localized scleroderma (LS) and systemic sclerosis (SSc). Both are
chronic conditions that can ma</span><span style=\"font-family:Verdana;\">nifest in
various patterns (subtypes) and are linked to extracutaneous in</span><span style=\"font-family:Verdana;\">volvement
in pediatric patients. Juvenile SSc poses a higher risk of morbidity and m</span><span style=\"font-family:Verdana;\">ortality, with patients facing life-threatening
complications such as lun</span><span style=\"font-family:Verdana;\">g, heart, and visceral organ fibrosis, and
vasculopathy. In contrast, mortality is extremely rare in juvenile LS, but
patients are susceptible to significant morbidity, leading to severe
disfigurement and functional impairment. Treatment for scleroderma aims to
control inflammation and address specific issues. An </span><span style=\"font-family:Verdana;\">early diagnosis significantly enhances the overall outcome. This study co</span><span style=\"font-family:Verdana;\">nducts
a retrospective descriptive analysis aiming to document the clinical
manifestations, management approaches, and outcomes of systemic sclerosis in a
cohort of nine children receiving treatment for juvenile systemic sclerosis at </span><span style=\"font-family:Verdana;\">Pediatric B department of Mohammed VI University,
Hospital Center in</span><span style=\"font-family:Verdana;\"> Marrakech, Morocco.
%K Scleroderma
%K Systemic Sclerosis
%K Children
%K Pediatric
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=131729